Home
Conditions
TDP-43 Proteinopathies

Clinical trial condition

TDP-43 Proteinopathies

Explore clinical trials studying TDP-43 Proteinopathies. Study availability and eligibility vary by location and protocol.

870 public trials 211 recruiting studies

Refine in advanced search Browse all conditions

TDP-43 Proteinopathies trial results

Completed

A Multicenter Phase I/II Clinical Trial to Evaluate Safety of Mesenchymal Stem Cell in Patients With Amyotrophic Sclerosis Lateral

NCT02290886

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: Hospital Regional Universitario Reina Sofía Córdoba, Spain

Hospital Regional Universitario de Málaga Málaga, Spain

Hospital Universitario Virgen Macarena, Servicio de Neurología Seville, Spain

Hospital Universitario Virgen del Rocío Seville, Spain

View Trial Details

Completed

Multidisciplinary and Personalized Care of Behavioral Disorders in Frontotemporal Lobar Degeneration.

NCT03606798

Conditions: Brain Diseases, Central Nervous System Diseases, Dementia, +9 more
Locations: Bordeaux University Hospital Bordeaux, France

View Trial Details

Completed

Multimodal Ocular Imaging in Neurodegeneration

NCT03699644

Conditions: Alzheimer Dementia, Alzheimer Disease, Brain Diseases, +13 more
Locations: University of Michigan Ann Arbor, Michigan, United States

View Trial Details

Completed

Safety and Efficacy Study of Autologous Bone Marrow Derived Stem Cell Treatment in Amyotrophic Lateral Sclerosis

NCT01363401

Conditions: ALS, Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, +9 more
Locations: Hanyang University Hospital Seoul, South Korea

View Trial Details

Completed

Innovative Ultrasound Technology in Neuromuscular Disease

NCT02104921

Conditions: Accidental Injuries, Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, +25 more
Locations: Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

View Trial Details

Completed

Treatment Continuation Study for Patients With ALS/MND Who Completed Study CMD-2019-001

NCT04313166

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: Macquarie University Macquarie Park, New South Wales, Australia

View Trial Details

Completed

DNA, Blood and Skin Cell Repository for Research on ALS and Related Neurodegenerative Disorders at Mayo Clinic Florida

NCT01699451

Conditions: Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +9 more
Locations: Mayo Clinic Florida Jacksonville, Florida, United States

View Trial Details

Completed

The E-health Application To Modify ORal Energy Intake and Measure Outcomes REmotely in ALS Clinical Trial (EAT MORE2)

NCT04051333

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Ciprofloxacin/Celecoxib Combination in Patients With ALS

NCT04090684

Conditions: ALS (Amyotrophic Lateral Sclerosis), Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, +9 more
Locations: Barrow Neurological Institute Phoenix, Arizona, United States

View Trial Details

Completed

Pathophysiology of Neurodegeneration in Late-life Depression (AV45+THK)

NCT03430869

Conditions: Brain Diseases, Central Nervous System Diseases, Dementia, +17 more
Locations: Chang Gung Memorial Hospital Taoyuan, Guishan, Taiwan

View Trial Details

TDP-43 Proteinopathies

TDP-43 Proteinopathies trial results

Related conditions